Latin America Insulin Market Research Report: Forecast (2024-2030)

Latin America Insulin Market Report - By Product Type (Insulin Drugs, (Insulin Analogs & Biosimilars, (Long Acting Biosimilars, Rapid Acting Biosimilars, Premixed Biosimilars), Ins......ulin Biologics, (Short Acting Biologics, Intermediate Acting Biologics, Premixed Biologics), Insulin Delivery Devices, (Insulin Syringes, Insulin Pens, (Disposable Insulin Pens, Reusable Insulin Pens, Insulin Pumps, (Tethered/External Pumps, Patch Pumps, Others (Needles, Injectors, etc.)), By Application (Type I Diabetes, Type II Diabetes), and Others Read more

  • Healthcare
  • Apr 2024
  • 146
  • PDF, Excel, PPT

Market Definition

Insulin is a pharmaceutical preparation of the protein hormone insulin produced by the human pancreas. It controls the amount of glucose (sugar) levels in the bloodstream, regulates the uptake of amino acids by body cells, and regulates the metabolism of fats, proteins, and carbohydrates.

Market Insights & Analysis: Latin America Insulin Market (2024-30):

The Latin America Insulin Market is estimated to grow at a CAGR of around 8.50% during the forecast period, i.e., 2024-30. The surge in several obese and overweight individuals at risk for diabetes has driven the Latin America Insulin Market. The old-age population has grown in Latin America and has accelerated the Latin America Insulin Market. For instance, as per the World Bank, there were 34,213,156 females aged 65 and over in Latin America and the Caribbean in 2022, up from 31,039,972 in 2019. Similarly, in 2022, there were 26,393,046 males aged 65 and over, an increase from 24,338,446 in 2019 in Latin America and the Caribbean. Also, according to the United Nations in Latin America and the Caribbean, the proportion of people aged 60 years and over will reach 16.5% of the total population by 2030, up from 13.4% in 2022. The percentage will further increase to 25.1% of the total population by 2050. Aging is one of the major causes of diabetes, and with the surge in the old-age population in Latin America, diabetes cases have increased in the region, which has accelerated the demand for insulin for effective management of diabetes.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-30
CAGR (2024-2030) 8.50%
Country Covered Brazil, Mexico, Argentina, Chile, Colombia, Peru, Rest of Latin America
Key Companies Profiled Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Wockhardt, Geropharm, Gan & Lee Pharmaceuticals, The United Laboratories International Holdings Limited (TUL), Beacon Pharmaceuticals PLC, Medtronic, and others 
Unit Denominations USD Million

 

Further, the surge in government and non-government initiatives aimed at raising awareness about diabetes in Latin America has accelerated the demand for insulin therapy by increasing the number of individuals undergoing diabetes screening and receiving subsequent treatment, which often involves insulin administration. Hence, all the factors mentioned above are expected to augment the size & volume of the Latin America Insulin Market collectively.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumption
  3. Executive Summary
  4. Latin America Insulin Market Trends & Insights
  5. Latin America Insulin Market Dynamics
    1. Growth Drivers
    2. Challenges
  6. Latin America Insulin Market Hotspot & Opportunities
  7. Latin America Insulin Market Regulation & Policy
  8. Latin America Insulin Market Outlook, 2019- 2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product Type
        1. Insulin Drugs- Market Size & Forecast 2019-2030, USD Million
          1. Insulin Analogs & Biosimilars- Market Size & Forecast 2019-2030, USD Million
            1. Long Acting Biosimilars- Market Size & Forecast 2019-2030, USD Million
            2. Rapid Acting Biosimilars- Market Size & Forecast 2019-2030, USD Million
            3. Premixed Biosimilars- Market Size & Forecast 2019-2030, USD Million
          2. Insulin Biologics- Market Size & Forecast 2019-2030, USD Million
            1. Short Acting Biologics- Market Size & Forecast 2019-2030, USD Million
            2. Intermediate Acting Biologics- Market Size & Forecast 2019-2030, USD Million
            3. Premixed Biologics- Market Size & Forecast 2019-2030, USD Million
        2. Insulin Delivery Devices- Market Size & Forecast 2019-2030, USD Million
          1. Insulin Syringes- Market Size & Forecast 2019-2030, USD Million
          2. Insulin Pens- Market Size & Forecast 2019-2030, USD Million
            1. Disposable Insulin Pens- Market Size & Forecast 2019-2030, USD Million
            2. Reusable Insulin Pens- Market Size & Forecast 2019-2030, USD Million
          3. Insulin Pumps- Market Size & Forecast 2019-2030, USD Million
            1. Tethered/External Pumps- Market Size & Forecast 2019-2030, USD Million
            2. Patch Pumps- Market Size & Forecast 2019-2030, USD Million
          4. Others (Needles, Injectors, etc.)- Market Size & Forecast 2019-2030, USD Million
      2. By Application
        1. Type I Diabetes- Market Size & Forecast 2019-2030, USD Million
        2. Type II Diabetes- Market Size & Forecast 2019-2030, USD Million
      3. By Countries
        1. Mexico
        2. Brazil
        3. Argentina
        4. Colombia
        5. Chile
        6. Peru
        7. Rest of Latin America
      4. By Company
        1. Competition Characteristics
        2. Revenue Shares
  9. Mexico Insulin Market Outlook, 2019- 2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product Type- Market Size & Forecast 2019-2030, USD Million
      2. By Application- Market Size & Forecast 2019-2030, USD Million
  10. Brazil Insulin Market Outlook, 2019- 2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product Type- Market Size & Forecast 2019-2030, USD Million
      2. By Application- Market Size & Forecast 2019-2030, USD Million
  11. Argentina Insulin Market Outlook, 2019- 2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product Type- Market Size & Forecast 2019-2030, USD Million
      2. By Application- Market Size & Forecast 2019-2030, USD Million
  12. Columbia Insulin Market Outlook, 2019- 2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product Type- Market Size & Forecast 2019-2030, USD Million
      2. By Application- Market Size & Forecast 2019-2030, USD Million
  13. Chile Insulin Market Outlook, 2019- 2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product Type- Market Size & Forecast 2019-2030, USD Million
      2. By Application- Market Size & Forecast 2019-2030, USD Million
  14. Peru Insulin Market Outlook, 2019- 2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product Type- Market Size & Forecast 2019-2030, USD Million
      2. By Application- Market Size & Forecast 2019-2030, USD Million
  15. Latin America Insulin Market Key Strategic Imperatives for Success & Growth
  16. Competitive Outlook
    1. Company Profiles
      1. Novo Nordisk A/S
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Eli Lilly and Company
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Sanofi S.A.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Biocon Limited
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Wockhardt
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Geropharm
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Gan & Lee Pharmaceuticals
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. The United Laboratories International Holdings Limited (TUL)
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Beacon Pharmaceuticals PLC 
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Medtronic
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Others
  17. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Related Reports
Talk to our Consultant Talk to our Consultant
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization Request Customization